HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ya-Ling Chan Selected Research

WRC 213

2/2008WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ya-Ling Chan Research Topics

Disease

4Neoplasms (Cancer)
07/2020 - 01/2008
1Carcinogenesis
07/2020
1Inflammation (Inflammations)
07/2020
1Hypoxia (Hypoxemia)
03/2019
1Prostatic Neoplasms (Prostate Cancer)
02/2008
1Colorectal Neoplasms (Colorectal Cancer)
02/2008
1Cardiotoxicity
02/2008
1Breast Neoplasms (Breast Cancer)
02/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2008
1Hepatocellular Carcinoma (Hepatoma)
02/2008

Drug/Important Bio-Agent (IBA)

1Protein Isoforms (Isoforms)IBA
07/2020
1Serotonin (5 Hydroxytryptamine)IBA
07/2020
1Internal Ribosome Entry SitesIBA
03/2019
1Proteins (Proteins, Gene)FDA Link
03/2019
1ProteomeIBA
03/2019
1Methionine (L-Methionine)FDA Link
02/2008
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2008
1AnthracyclinesIBA
02/2008
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2008
1Topoisomerase II InhibitorsIBA
02/2008
1AndrogensIBA
02/2008
1AnthraquinonesIBA
02/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
02/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2008
1Etoposide (VP 16)FDA LinkGeneric
02/2008
1WRC 213IBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2008